Published • loading... • Updated
PHR Deadline: PHR Investors with Losses in Excess of $100K Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit
The firm says eligible investors may seek compensation as a class action accuses Phreesia of hiding slowing demand and weaker pharmaceutical marketing commitments.
- Rosen Law Firm reminded investors on July 4 of the July 13, 2026 lead plaintiff deadline for the securities class action lawsuit against Phreesia, Inc. involving allegations of misleading financial disclosures.
- The lawsuit alleges that during the Class Period spanning May 8, 2025 to March 30, 2026, Phreesia defendants concealed material adverse facts regarding slowing demand and weakened pharmaceutical marketing commitments in its Network Solutions segment.
- Investors who purchased Phreesia common stock during this period may be eligible for compensation without out-of-pocket costs through a contingency fee arrangement, with information available from Phillip Kim, Esq.
- A lead plaintiff acts as a representative party directing the litigation, a function Rosen Law Firm has supported in numerous cases while securing over $438 million for investors.
- Shareholders seeking to serve as lead plaintiff must file with the Court no later than July 13, 2026 to participate as a representative party in the ongoing class action.
Insights by Ground AI
41 Articles
41 Articles
Coverage Details
Total News Sources41
Leaning Left2Leaning Right5Center20Last UpdatedBias Distribution74% Center
Bias Distribution
- 74% of the sources are Center
74% Center
C 74%
R 19%
Factuality
To view factuality data please Upgrade to Premium
